anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Alkermes · conference-presentation

Alkermes | Investor Presentation Deck | 28 slides

28 pages · 4 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

Alkermes | Investor Presentation Deck | 28 slides

Alkermes · 2023-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 28 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 3 slides 100% 3/3 slides 100% 3/3 slides · 17 hits
— 0/3 slides
66.7% 2/3 slides 33.3% 1/3 slides 100% 3/3 slides
— 0/3 slides
Need 3 slides 100% 3/3 slides 100% 3/3 slides · 9 hits
— 0/3 slides
33.3% 1/3 slides 66.7% 2/3 slides 100% 3/3 slides
— 0/3 slides
Satisfaction 6 slides 100% 6/6 slides 100% 6/6 slides · 25 hits
— 0/6 slides
50% 3/6 slides
— 0/6 slides
100% 6/6 slides 100% 6/6 slides Action 16 slides 100% 16/16 slides 100% 16/16 slides · 63 hits
— 0/16 slides
62.5% 10/16 slides · 11 hits 25% 4/16 slides 100% 16/16 slides 43.8% 7/16 slides

Slide inventory

28
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
front_matter
Open slide detailBeat · Attention
03
The slide uses a hub-and-spoke diagram to represent the company's business model.establish_context
Open slide detailBeat · Attention
04
The slide uses a hub-and-spoke diagram to show the core business (Alkermes) and its various value drivers, with a separate node for the proposed Oncology Companpresent_solution
Open slide detailBeat · Need
05
prioritize
Open slide detailBeat · Need
06
transition
Open slide detailBeat · Need
07
Includes a boxed warning disclaimer at the bottom.establish_context
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
08
The chart shows a steady upward trend in total prescriptions (TRx) over 61 weeks, with a notable dip around week 58.analyze_data
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
09
size_opportunity
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
10
The slide uses a combination of a treatment matrix and a donut chart to align product labeling with real-world patient needs.analyze_data
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
11
The slide includes a disclaimer regarding the boxed warning for the drug.present_solution
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
12
summarize
Open slide detailBeat · SatisfactionLoop · Pattern Hunter
13
transition
Open slide detailBeat · ActionLoop · Why Now
14
The slide uses a medical illustration of the brain to show neurotransmitter pathways.diagnose_problem
Open slide detailBeat · ActionLoop · Why Now
15
Includes a molecular structure visualization of the Orexin 2 receptor.present_solution
Open slide detailBeat · ActionLoop · Why Now
16
The slide presents preclinical efficacy data for RDC-264177 using a DTA mouse model.analyze_data
Open slide detailBeat · ActionLoop · Why Now
17
The slide uses PharmacoEEG heatmaps to visualize brain activity frequency over time.analyze_data
Open slide detailBeat · ActionLoop · Why Now
18
The slide uses a process flow diagram to illustrate the progression from Single Ascending Dose to Multiple Ascending Dose and Proof-of-Concept studies.plan_implementation
Open slide detailBeat · ActionLoop · Why Now
19
The slide uses a side-by-side comparison layout to delineate two distinct clinical trial phases.plan_implementation
Open slide detailBeat · ActionLoop · Why Now
20
transition
Open slide detailBeat · Action
21
The slide outlines the core assets (nemvaleukin alfa, IL-12, IL-18) and the strategic rationale for a spin-off.summarize
Open slide detailBeat · Action
22
The slide uses a human body diagram to map clinical responses (CR, PR, uPR) by tumor type.summarize
Open slide detailBeat · Action
23
The slide uses a 2x2 matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.present_framework
Open slide detailBeat · Action
24
front_matter
Open slide detailBeat · Action
25
The slide outlines the strategic rationale for a corporate spin-off, focusing on the remaining neuroscience-focused entity.summarize
Open slide detailBeat · Action
26
The chart tracks revenue for VIVITROL, ARISTADA, VUMERITY, and LYBALVI.analyze_data
Open slide detailBeat · Action
27
prioritize
Open slide detailBeat · Action
28
state_next_steps
Open slide detailBeat · Action